Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1202577-82-9

Post Buying Request

1202577-82-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (1S)-4-(Trifluoromethyl)indan-1-ol, (1S)-2,3-Dihydro-4-(trifluoromethyl)-1H-inden-1-ol, (1S)-2,3-Dihydro-1-hydroxy-4-(trifluoromethyl)-1H-indene

    Cas No: 1202577-82-9

  • No Data

  • No Data

  • No Data

  • ZHEJIANG JIUZHOU CHEM CO.,LTD
  • Contact Supplier

1202577-82-9 Usage

General Description

These are all different names for the same chemical compound, which is an alcohol with a trifluoromethyl group attached to an indene or indan backbone. It has the chemical formula C10H9F3O. (1S)-4-(Trifluoromethyl)indan-1-ol, (1S)-2,3-Dihydro-4-(trifluoromethyl)-1H-inden-1-ol, (1S)-2,3-Dihydro-1-hydroxy-4-(trifluoromethyl)-1H-indene can be used as a building block in organic synthesis to create more complex molecules, and it also has potential applications in pharmaceutical research due to its unique structure and properties. Additionally, the trifluoromethyl group is known to impact the compound's reactivity and its interactions with biological systems.

Check Digit Verification of cas no

The CAS Registry Mumber 1202577-82-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,2,5,7 and 7 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1202577-82:
(9*1)+(8*2)+(7*0)+(6*2)+(5*5)+(4*7)+(3*7)+(2*8)+(1*2)=129
129 % 10 = 9
So 1202577-82-9 is a valid CAS Registry Number.

1202577-82-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-ol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1202577-82-9 SDS

1202577-82-9Relevant articles and documents

NOVEL SALTS

-

Paragraph 0058; 0059; 0060; 0061, (2016/10/27)

Salts of 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid of the formula (I), in particular amino acid salts such as the lysine salt and alkali metal salts such as the sodium salt and the potassium salt, processes for their preparation, medicaments comprising them and their use for controlling diseases.

Optimization of 3-aryl-3-ethoxypropanoic acids and discovery of the potent GPR40 agonist DS-1558

Takano, Rieko,Yoshida, Masao,Inoue, Masahiro,Honda, Takeshi,Nakashima, Ryutaro,Matsumoto, Koji,Yano, Tatsuya,Ogata, Tsuneaki,Watanabe, Nobuaki,Hirouchi, Masakazu,Kimura, Takako,Toda, Narihiro

supporting information, p. 5546 - 5565 (2015/11/11)

GPR40 agonists stimulate insulin secretion only under the presence of high glucose concentration. Based on this mechanism, GPR40 agonists are believed to be promising novel insulin secretagogues with low risk of hypoglycemia. The optimizations of 3-aryl-3-ethoxypropanoic acids were performed to improve in vitro activity. We discovered compound 29r (DS-1558), (3S)-3-ethoxy-3-(4-{[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)propanoic acid, which was confirmed to have an enhancing effect on glucose-dependent insulin secretion after intravenous glucose injection in SD rats.

INDANYLOXYPHENYLCYCLOPROPANECARBOXYLIC ACIDS

-

Paragraph 0389, (2014/01/07)

The present invention relates to compounds of general formula I, wherein the groups R1, R2, R3, m and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1202577-82-9